{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:55:13Z","timestamp":1788897313305,"version":"build-2803163510"},"reference-count":37,"publisher":"American Society of Hematology","issue":"27","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,26]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Individuals with MGUS did not have a decreased BMD compared with others in a screened population. Individuals with MGUS had an increased bone volume at the hip and lumbar spine compared with others.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017010454","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T01:30:37Z","timestamp":1513906237000},"page":"2790-2798","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":33,"title":["Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study"],"prefix":"10.1182","volume":"1","author":[{"given":"Sigrun","family":"Thorsteinsdottir","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Landspitali\u2013The National University Hospital of Iceland, Reykjavik, Iceland;"},{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun H.","family":"Lund","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba K.","family":"Lindqvist","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Thordardottir","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Sigurdsson","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association, Kopavogur, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Costello","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Burton","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hlif","family":"Steingrimsdottir","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Landspitali\u2013The National University Hospital of Iceland, Reykjavik, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"},{"name":"Icelandic Heart Association, Kopavogur, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudny","family":"Eiriksdottir","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association, Kopavogur, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Siggeirsdottir","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association, Kopavogur, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara B.","family":"Harris","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[{"name":"Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur Y.","family":"Kristinsson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Landspitali\u2013The National University Hospital of Iceland, Reykjavik, Iceland;"},{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"issue":"9727","key":"2019111617284001100_B1","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"2019111617284001100_B2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111617284001100_B3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/erm.11.44","article-title":"Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management","volume":"11","author":"Kristinsson","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"issue":"15","key":"2019111617284001100_B4","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","article-title":"Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study","volume":"116","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111617284001100_B5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.06269.x","article-title":"Fracture risk in patients with monoclonal gammopathy of undetermined significance","volume":"135","author":"Gregersen","year":"2006","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111617284001100_B6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4065\/84.8.685","article-title":"Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients","volume":"84","author":"Bida","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2019111617284001100_B7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study","volume":"20","author":"Melton","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2019111617284001100_B8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","article-title":"Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance","volume":"134","author":"Pepe","year":"2006","journal-title":"Br J Haematol"},{"issue":"7495","key":"2019111617284001100_B9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/bmj.38376.401701.8F","article-title":"Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study","volume":"330","author":"Abrahamsen","year":"2005","journal-title":"BMJ"},{"issue":"7","key":"2019111617284001100_B10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00198-007-0525-7","article-title":"Secondary contributors to bone loss in osteoporosis related hip fractures","volume":"19","author":"Edwards","year":"2008","journal-title":"Osteoporos Int"},{"issue":"1","key":"2019111617284001100_B11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11657-016-0258-3","article-title":"High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD","volume":"11","author":"Malgo","year":"2016","journal-title":"Arch Osteoporos"},{"issue":"2","key":"2019111617284001100_B12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000162282","article-title":"Prevalence of monoclonal gammopathy of undetermined significance\/myeloma in patients with acute osteoporotic vertebral fractures","volume":"120","author":"Golombick","year":"2008","journal-title":"Acta Haematol"},{"issue":"2","key":"2019111617284001100_B13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jbspin.2009.12.002","article-title":"Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis","volume":"77","author":"Bouvard","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"3","key":"2019111617284001100_B14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jbmr.2069","article-title":"Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans","volume":"29","author":"Kopperdahl","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019111617284001100_B15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jocd.2013.03.005","article-title":"Fracture risk assessment in older adults using a combination of selected quantitative computed tomography bone measures: a subanalysis of the Age, Gene\/Environment Susceptibility-Reykjavik Study","volume":"17","author":"Rianon","year":"2014","journal-title":"J Clin Densitom"},{"issue":"25","key":"2019111617284001100_B16","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1182\/blood-2011-04-351437","article-title":"Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1\u03b1 levels in patients with MGUS","volume":"118","author":"Ng","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111617284001100_B17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2013-05-505776","article-title":"Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance","volume":"123","author":"Farr","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2019111617284001100_B18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/clinchem\/47.4.686","article-title":"Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis","volume":"47","author":"Woitge","year":"2001","journal-title":"Clin Chem"},{"issue":"4","key":"2019111617284001100_B19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02230356","article-title":"Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma","volume":"15","author":"Laroche","year":"1996","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2019111617284001100_B20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0609.1997.tb00932.x","article-title":"Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens","volume":"58","author":"Vejlgaard","year":"1997","journal-title":"Eur J Haematol"},{"issue":"5","key":"2019111617284001100_B21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2004.05092.x","article-title":"Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)","volume":"126","author":"Politou","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111617284001100_B22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bone.2006.03.020","article-title":"Increasing sex difference in bone strength in old age: The Age, Gene\/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK)","volume":"39","author":"Sigurdsson","year":"2006","journal-title":"Bone"},{"key":"2019111617284001100_B23","author":"Bjornsson","year":"1979"},{"key":"2019111617284001100_B24","author":"Bjornsson","year":"1982"},{"issue":"9","key":"2019111617284001100_B25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10654-007-9163-9","article-title":"Inaccuracy in self-report of fractures may underestimate association with health outcomes when compared with medical record based fracture registry","volume":"22","author":"Siggeirsdottir","year":"2007","journal-title":"Eur J Epidemiol"},{"issue":"10027","key":"2019111617284001100_B26","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(15)01120-4","article-title":"Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial","volume":"387","author":"Lonial","year":"2016","journal-title":"Lancet"},{"issue":"1-2","key":"2019111617284001100_B27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10428199809059252","article-title":"Biologic and therapeutic determinants of bone mineral density in multiple myeloma","volume":"32","author":"Dhodapkar","year":"1998","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2019111617284001100_B28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0609.1996.tb01395.x","article-title":"Assessment of bone involvement in patients with multiple myeloma using bone densitometry","volume":"57","author":"Abildgaard","year":"1996","journal-title":"Eur J Haematol"},{"key":"2019111617284001100_B29","article-title":"Bone mineral density utilization in patients with newly diagnosed multiple myeloma [published online ahead of print 21 June 2016]","author":"Muchtar","journal-title":"Hematol Oncol"},{"issue":"4","key":"2019111617284001100_B30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bone.2010.12.004","article-title":"Effects of age and sex on the strength and cortical thickness of the femoral neck","volume":"48","author":"Carpenter","year":"2011","journal-title":"Bone"},{"issue":"1","key":"2019111617284001100_B31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2019111617284001100_B32","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1038\/bcj.2015.71","article-title":"Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance","volume":"5","author":"Piot","year":"2015","journal-title":"Blood Cancer J"},{"issue":"2","key":"2019111617284001100_B33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-122-2-199501150-00003","article-title":"Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study","volume":"122","author":"Sigurdsson","year":"1995","journal-title":"Ann Intern Med"},{"issue":"5","key":"2019111617284001100_B34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF01623015","article-title":"Correlations of dual-energy x-ray absorptiometry, quantitative computed tomography, and single photon absorptiometry with spinal and non-spinal fractures","volume":"6","author":"Lafferty","year":"1996","journal-title":"Osteoporos Int"},{"key":"2019111617284001100_B35","article-title":"Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis [published online ahead of print 27 February 2017]","author":"Veronese","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"2019111617284001100_B36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00223-008-9145-2","article-title":"The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance","volume":"82","author":"Pepe","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"19","key":"2019111617284001100_B37","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/1078-0432.CCR-08-0666","article-title":"Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss","volume":"14","author":"Berenson","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/27\/2790\/879240\/advances010454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/27\/2790\/879240\/advances010454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T18:29:07Z","timestamp":1603564147000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/27\/2790\/15819\/Bone-disease-in-monoclonal-gammopathy-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":37,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2017,12,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017010454","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}